메뉴 건너뛰기




Volumn 25, Issue 7, 2010, Pages 1305-1310

Management of regional citrate anticoagulation in pediatric high-flux dialysis: Activated coagulation time versus post-filter ionized calcium

Author keywords

Children; Coagulation management; High flux hemodialysis; Post filter ionized calcium; Regional citrate anticoagulation

Indexed keywords

CALCIUM ION; CITRIC ACID; GLUCONATE CALCIUM;

EID: 77954535095     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-010-1483-4     Document Type: Article
Times cited : (18)

References (29)
  • 1
    • 0001908589 scopus 로고
    • Regional anticoagulation during hemodialysis using citrate
    • Morita Y, Johnson RW, Dorn RE, Hall DS (1961) Regional anticoagulation during hemodialysis using citrate. Am J Med Sci 242:32-43
    • (1961) Am J Med Sci , vol.242 , pp. 32-43
    • Morita, Y.1    Johnson, R.W.2    Dorn, R.E.3    Hall, D.S.4
  • 2
    • 0020693079 scopus 로고
    • Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding
    • Pinnick RV, Wiegmann TB, Diederich DA (1983) Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. N Engl J Med 308:258-261
    • (1983) N Engl J Med , vol.308 , pp. 258-261
    • Pinnick, R.V.1    Wiegmann, T.B.2    Diederich, D.A.3
  • 3
    • 0025089550 scopus 로고
    • Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients
    • Mehta R, McDonald B, Aguilar M, Ward DM (1990) Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 38:976-981
    • (1990) Kidney Int , vol.38 , pp. 976-981
    • Mehta, R.1    McDonald, B.2    Aguilar, M.3    Ward, D.M.4
  • 4
    • 38849176333 scopus 로고    scopus 로고
    • Regional citrate anticoagulation for single-needle hemodialysis: A prospective clinical study
    • Gubensek J, Buturovic-Ponikvar J, Ponikvar R (2007) Regional citrate anticoagulation for single-needle hemodialysis: a prospective clinical study. Blood Purif 25:454-456
    • (2007) Blood Purif , vol.25 , pp. 454-456
    • Gubensek, J.1    Buturovic-Ponikvar, J.2    Ponikvar, R.3
  • 7
    • 0344826831 scopus 로고    scopus 로고
    • Pediatric convective hemofiltration: Normocarb replacement fluid and citrate anticoagulation
    • Bunchman TE, Maxvold NJ, Brophy PD (2003) Pediatric convective hemofiltration: Normocarb replacement fluid and citrate anticoagulation. Am J Kidney Dis 42:1248-1252
    • (2003) Am J Kidney Dis , vol.42 , pp. 1248-1252
    • Bunchman, T.E.1    Maxvold, N.J.2    Brophy, P.D.3
  • 8
    • 0036947439 scopus 로고    scopus 로고
    • Citrate clearance in children receiving continuous venovenous renal replacement therapy
    • Chadha V, Garg U, Warady BA, Alon US (2002) Citrate clearance in children receiving continuous venovenous renal replacement therapy. Pediatr Nephrol 17:819-824
    • (2002) Pediatr Nephrol , vol.17 , pp. 819-824
    • Chadha, V.1    Garg, U.2    Warady, B.A.3    Alon, U.S.4
  • 9
    • 0842323883 scopus 로고    scopus 로고
    • Citrate anticoagulation in pediatric continuous venovenous hemofiltration
    • Elhanan N, Skippen P, Nuthall G, Krahn G, Seear M (2004) Citrate anticoagulation in pediatric continuous venovenous hemofiltration. Pediatr Nephrol 19:208-212
    • (2004) Pediatr Nephrol , vol.19 , pp. 208-212
    • Elhanan, N.1    Skippen, P.2    Nuthall, G.3    Krahn, G.4    Seear, M.5
  • 11
    • 0030933750 scopus 로고    scopus 로고
    • The approach to anticoagulation in patients treated with extracorporeal therapy in the intensive care unit
    • Ward DM (1997) The approach to anticoagulation in patients treated with extracorporeal therapy in the intensive care unit. Adv Ren Replace Ther 4:160-173
    • (1997) Adv Ren Replace Ther , vol.4 , pp. 160-173
    • Ward, D.M.1
  • 12
    • 0027981799 scopus 로고
    • Calcium threshold in human plasma clotting kinetics
    • Ataullakhanov F, Pohilko A, Sinauridze E (1994) Calcium threshold in human plasma clotting kinetics. Thromb Res 75:383-394
    • (1994) Thromb Res , vol.75 , pp. 383-394
    • Ataullakhanov, F.1    Pohilko, A.2    Sinauridze, E.3
  • 13
    • 0034824516 scopus 로고    scopus 로고
    • Citrate anticoagulation for extracorporeal circuits: Effects on whole blood coagulation activation and clot formation
    • Calatzis A, Toepfer M, Schramm W, Spannagl M, Schiffl H (2001) Citrate anticoagulation for extracorporeal circuits: effects on whole blood coagulation activation and clot formation. Nephron 89:233-236
    • (2001) Nephron , vol.89 , pp. 233-236
    • Calatzis, A.1    Toepfer, M.2    Schramm, W.3    Spannagl, M.4    Schiffl, H.5
  • 14
    • 0014004037 scopus 로고
    • Activated coagulation time of whole blood
    • Hattersley PG (1966) Activated coagulation time of whole blood. JAMA 196:436-440
    • (1966) JAMA , vol.196 , pp. 436-440
    • Hattersley, P.G.1
  • 15
    • 52149114450 scopus 로고    scopus 로고
    • Perioperative coagulation management and blood conservation in cardiac surgery: A Canadian survey
    • Taneja R, Fernandes P, Marwaha G, Cheng D, Bainbridge D (2008) Perioperative coagulation management and blood conservation in cardiac surgery: a Canadian Survey. J Cardiothorac Vasc Anesth 22:662-669
    • (2008) J Cardiothorac Vasc Anesth , vol.22 , pp. 662-669
    • Taneja, R.1    Fernandes, P.2    Marwaha, G.3    Cheng, D.4    Bainbridge, D.5
  • 16
    • 38849159222 scopus 로고    scopus 로고
    • A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass
    • Slight RD, Buell R, Nzewi OC, McClelland DB, Mankad PS (2008) A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth 22:47-52
    • (2008) J Cardiothorac Vasc Anesth , vol.22 , pp. 47-52
    • Slight, R.D.1    Buell, R.2    Nzewi, O.C.3    McClelland, D.B.4    Mankad, P.S.5
  • 17
    • 0029934065 scopus 로고    scopus 로고
    • The activated coagulation time: Suitability for monitoring heparin effect and neutralization during pediatric cardiac surgery
    • Martindale SJ, Shayevitz JR, D'Errico C (1996) The activated coagulation time: suitability for monitoring heparin effect and neutralization during pediatric cardiac surgery. J Cardiothorac Vasc Anesth 10:458-463
    • (1996) J Cardiothorac Vasc Anesth , vol.10 , pp. 458-463
    • Martindale, S.J.1    Shayevitz, J.R.2    D'Errico, C.3
  • 18
    • 0015065072 scopus 로고
    • The activated coagulation time of whole blood as a routine pre-operative sceening test
    • Hattersley PG (1971) The activated coagulation time of whole blood as a routine pre-operative sceening test. Calif Med 114:15-18
    • (1971) Calif Med , vol.114 , pp. 15-18
    • Hattersley, P.G.1
  • 20
    • 77954542561 scopus 로고    scopus 로고
    • Anticoagulation options for pediatric hemodialysis
    • Davenport A (2003) Anticoagulation options for pediatric hemodialysis. Hemodial Int 7:168-176
    • (2003) Hemodial Int , vol.7 , pp. 168-176
    • Davenport, A.1
  • 21
    • 52149091971 scopus 로고    scopus 로고
    • An unusual cause of a prolonged activated coagulation time during cardiac surgery: Congenital hypofibrinogenemia
    • Rani TR, Gopinath R (2008) An unusual cause of a prolonged activated coagulation time during cardiac surgery: congenital hypofibrinogenemia. J Cardiothorac Vasc Anesth 22:725-726
    • (2008) J Cardiothorac Vasc Anesth , vol.22 , pp. 725-726
    • Rani, T.R.1    Gopinath, R.2
  • 22
    • 0031693646 scopus 로고    scopus 로고
    • How does warfarin affect the activated coagulation time?
    • Chang RJ, Doherty TM, Goldberg SL (1998) How does warfarin affect the activated coagulation time? Am Heart J 136:477-479
    • (1998) Am Heart J , vol.136 , pp. 477-479
    • Chang, R.J.1    Doherty, T.M.2    Goldberg, S.L.3
  • 23
    • 0029441639 scopus 로고
    • Influence of coagulation parameters on filter running time during continuous venovenous hemofiltration
    • Stefanidis I, Hägel J, Maurin N (1995) Influence of coagulation parameters on filter running time during continuous venovenous hemofiltration. Contrib Nephrol 116:145-149
    • (1995) Contrib Nephrol , vol.116 , pp. 145-149
    • Stefanidis, I.1    Hägel, J.2    Maurin, N.3
  • 24
    • 0036210868 scopus 로고    scopus 로고
    • Comparison between tinzaparin and standard heparin for chronic hemodialysis in a Canadian center
    • Lord H, Jean N, Dumont M, Kassis J, Leblanc M (2002) Comparison between tinzaparin and standard heparin for chronic hemodialysis in a Canadian center. Am J Nephrol 22:58-66
    • (2002) Am J Nephrol , vol.22 , pp. 58-66
    • Lord, H.1    Jean, N.2    Dumont, M.3    Kassis, J.4    Leblanc, M.5
  • 25
    • 33646373411 scopus 로고    scopus 로고
    • Thrombocytopathy and bleeding complications in Uremia
    • Hörl WH (2006) Thrombocytopathy and bleeding complications in Uremia. Wien Klin Wochenschr 118:134-150
    • (2006) Wien Klin Wochenschr , vol.118 , pp. 134-150
    • Hörl, W.H.1
  • 26
    • 0036218363 scopus 로고    scopus 로고
    • Citrate anticoagulation in a piglet model of pediatric continuous renal replacement therapy
    • Nuthall G, Skippen P, Daoust C, Al-Jofan F, Seear M (2002) Citrate anticoagulation in a piglet model of pediatric continuous renal replacement therapy. Crit Care Med 30:900-903
    • (2002) Crit Care Med , vol.30 , pp. 900-903
    • Nuthall, G.1    Skippen, P.2    Daoust, C.3    Al-Jofan, F.4    Seear, M.5
  • 27
    • 33746608575 scopus 로고    scopus 로고
    • Detection of citrate overdose in critically ill patients on citrate-anticoagulated venovenous hemofiltration: Use of ionized and total/ionized calcium
    • Bakker AJ, Boerma EC, Keidel H, Kingma P, Van Der Voort PH (2006) Detection of citrate overdose in critically ill patients on citrate- anticoagulated venovenous hemofiltration: use of ionized and total/ionized calcium. Clin Chem Lab Med 44:962-966
    • (2006) Clin Chem Lab Med , vol.44 , pp. 962-966
    • Bakker, A.J.1    Boerma, E.C.2    Keidel, H.3    Kingma, P.4    Van Der Voort, P.H.5
  • 28
    • 33847673290 scopus 로고    scopus 로고
    • Citrate anticoagulation control by ionized calcium levels does not prevent hemostasis and complement activation during hemodialysis
    • Opatrný K, Richtrová P, Polanská K, Wirth J, Sefrna F, Brandl M, Falkenhagen D (2007) Citrate anticoagulation control by ionized calcium levels does not prevent hemostasis and complement activation during hemodialysis. Artif Organs 31:200-207
    • (2007) Artif Organs , vol.31 , pp. 200-207
    • Opatrný, K.1    Richtrová, P.2    Polanská, K.3    Wirth, J.4    Sefrna, F.5    Brandl, M.6    Falkenhagen, D.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.